GatePass Capital’s Pfizer PFE Stock Holding History

GatePass Capital’s Portfolio PFE Stock Details PFE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$578K	Sell	23,985 -188	-0.8%	-$4.92K	0.22%	108
2026 Q1	$679K	Buy	24,173 +1,044	+5%	+$27.8K	0.32%	78
2025 Q4	$576K	Sell	23,129 -25,887	-53%	-$653K	0.3%	84
2025 Q3	$1.25M	Buy	49,016 +108	+0.2%	+$2.67K	0.72%	37
2025 Q2	$1.19M	Sell	48,908 -16,884	-26%	-$394K	0.79%	28
2025 Q1	$1.67M	Buy	65,792 +20,792	+46%	+$544K	1.25%	19
2024 Q4	$1.19M	Buy	+45,000	New	+$1.22M	1.3%	20

Other funds holding PFE

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GatePass Capital's PFE Position: Q2 2026 in Review

GatePass Capital reduced its Pfizer (PFE) stake by 0.78% in Q2 2026, selling an estimated $4.92K and leaving 23,985 shares worth $578K. The position accounts for 0.22% of the portfolio, ranked #108.

GatePass Capital first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.67M in Q1 2025. 2,822 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

GatePass Capital held 23,985 shares of Pfizer worth $578K as of Q2 2026.
GatePass Capital sold 188 Pfizer shares in Q2 2026, an estimated $4.92K.
Pfizer made up 0.22% of GatePass Capital's portfolio in Q2 2026, its #108 holding.
GatePass Capital first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
GatePass Capital's Pfizer position peaked at $1.67M in Q1 2025.
2,822 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on GatePass Capital's 13F filing for Q2 2026, filed 30 Jul 2026.